Stories - Corcept Therapeutics

Stories and perspectives.

Featured
Stories

We are Corcept.

Founding Corcept

All Stories

FDA Files Corcept’s New Drug Application for Relacorilant as Treatment for Patients With Hypercortisolism

Press Release: Mar 3, 2025

A Simple Test, A Life-Changing Diagnosis: The Cortisol Connection

Honoring Rosalyn Yalow, Ph.D.

Honoring Dr. LaSalle D. Leffall Jr.

Corcept Submits New Drug Application for Relacorilant as a Treatment for Patients With Hypercortisolism

Press Release: Dec 30, 2024

Corcept’s Phase 3 Long-Term Extension Study of Relacorilant Demonstrated Durable Cardiometabolic Improvements in Patients with Hypercortisolism

Press Release: Dec 16, 2024

Corcept Announces Positive Results in Treatment Phase of CATALYST Trial in Patients With Hypercortisolism (Cushing’s Syndrome) and Difficult-to-Control Diabetes

Press Release: Dec 14, 2024

‘Constantly stressed out’: A woman’s battle with excess cortisol

Honoring Ildaura Murillo-Rohde